The Latest Headlines at American Banking and Market News
Oxford Nanopore Technologies’ (ONT) “Buy” Rating Reaffirmed at Berenberg Bank
Berenberg Bank reissued their buy rating on shares of Oxford Nanopore Technologies (LON:ONT – Free Report) in a research report sent to investors on Wednesday morning, LSE.Co.UK reports. They currently have a GBX 350 ($4.36)... More of this article »
Liontrust Asset Management (LON:LIO) Given Hold Rating at Berenberg Bank
Berenberg Bank reaffirmed their hold rating on shares of Liontrust Asset Management (LON:LIO – Free Report) in a report issued on Wednesday morning, Marketbeat reports. The brokerage currently has a GBX 750 ($9.34) target price... More of this article »
GSK (LON:GSK) Given Buy Rating at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of GSK (LON:GSK – Free Report) in a research report released on Wednesday morning, Marketbeat reports. Deutsche Bank Aktiengesellschaft currently has a GBX... More of this article »
Entain’s (ENT) Buy Rating Reaffirmed at Shore Capital
Shore Capital restated their buy rating on shares of Entain (LON:ENT – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. Other research analysts have also recently issued research... More of this article »
ASOS (LON:ASC) Receives “Sell” Rating from Shore Capital
Shore Capital reaffirmed their sell rating on shares of ASOS (LON:ASC – Free Report) in a report issued on Wednesday morning, Marketbeat reports. Separately, Berenberg Bank restated a buy rating and issued a GBX 600 ($7.47)... More of this article »
Brooks Macdonald Group (LON:BRK) Given “Buy” Rating at Shore Capital
Shore Capital reissued their buy rating on shares of Brooks Macdonald Group (LON:BRK – Free Report) in a research report released on Wednesday, MarketBeat reports. Brooks Macdonald Group Trading Up 3.4 % LON:BRK opened at GBX... More of this article »
Deltic Energy’s (DELT) “Speculative Buy” Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reissued their speculative buy rating on shares of Deltic Energy (LON:DELT – Free Report) in a research report report published on Wednesday morning, MarketBeat reports. They currently have a GBX 160... More of this article »
ASOS (LON:ASC) Price Target Lowered to GBX 490 at Berenberg Bank
ASOS (LON:ASC – Free Report) had its price target reduced by Berenberg Bank from GBX 510 ($6.35) to GBX 490 ($6.10) in a research report report published on Wednesday, MarketBeat Ratings reports. They currently have a buy rating... More of this article »
B&M European Value Retail (LON:BME) Receives “Buy” Rating from Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of B&M European Value Retail (LON:BME – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. Deutsche Bank... More of this article »
Wix.com (NASDAQ:WIX) Price Target Cut to $143.00 by Analysts at Morgan Stanley
Wix.com (NASDAQ:WIX – Free Report) had its target price decreased by Morgan Stanley from $157.00 to $143.00 in a report issued on Wednesday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the... More of this article »
Tesla (NASDAQ:TSLA) Price Target Lowered to $180.00 at Barclays
Tesla (NASDAQ:TSLA – Free Report) had its price objective trimmed by Barclays from $225.00 to $180.00 in a research report released on Wednesday, Marketbeat reports. The brokerage currently has an equal weight rating on the electric... More of this article »
AO World (LON:AO) Price Target Raised to GBX 75 at Canaccord Genuity Group
AO World (LON:AO – Free Report) had its price target raised by Canaccord Genuity Group from GBX 52 ($0.65) to GBX 75 ($0.93) in a research note released on Wednesday, MarketBeat reports. They currently have a sell rating on the... More of this article »
Viracta Therapeutics (NASDAQ:VIRX) Given “Outperform” Rating at Oppenheimer
Oppenheimer restated their outperform rating on shares of Viracta Therapeutics (NASDAQ:VIRX – Free Report) in a research note released on Wednesday, Benzinga reports. The firm currently has a $13.00 price target on the stock. Separately,... More of this article »